真菌乙酰辅酶a合成酶抑制剂酰基amp磷酸同异构体的合成及评价。

IF 2.2 4区 医学 Q3 CHEMISTRY, MEDICINAL
Drashti G. Daraji , Andrew J. Jezewski , Katy M. Alden , Jonah P. Propp , Michael E. Heene , Calvin A. Soldan , Lijun Liu , Kevin P. Battaile , Scott Lovell , Bart L. Staker , Damian J. Krysan , Timothy J. Hagen
{"title":"真菌乙酰辅酶a合成酶抑制剂酰基amp磷酸同异构体的合成及评价。","authors":"Drashti G. Daraji ,&nbsp;Andrew J. Jezewski ,&nbsp;Katy M. Alden ,&nbsp;Jonah P. Propp ,&nbsp;Michael E. Heene ,&nbsp;Calvin A. Soldan ,&nbsp;Lijun Liu ,&nbsp;Kevin P. Battaile ,&nbsp;Scott Lovell ,&nbsp;Bart L. Staker ,&nbsp;Damian J. Krysan ,&nbsp;Timothy J. Hagen","doi":"10.1016/j.bmcl.2025.130389","DOIUrl":null,"url":null,"abstract":"<div><div>Acetyl-CoA synthetase (ACS) is a member of the adenylate-forming enzymes superfamily. This enzyme plays a crucial role in cellular metabolism. While ACS enzymes are non-essential in mammals, they are essential in some fungal species and parasites that are pathogenic to humans. Hence, inhibition of the ACS enzyme is an emerging target for the development of novel anti-infectives. Alkyl AMP esters and acyl sulfamoyl adenosine (Acyl-AMS) are potent inhibitors of fungal ACS enzymes by mimicingthe acyl-AMP enzyme intermediate. Molecular docking studies were performed to facilitate the design of analogs and to explore their potential ligand-binding interactions with the ACS enzyme. A series of acyl-AMP isosteres were synthesized and screened for inhibitory activity against fungal ACS enzymes. Notably, Compound <strong>14</strong> was successfully crystallized with the <em>Cryptococcus neoformans</em> ACS1 enzyme, providing valuable structural insight for future inhibitor design.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"129 ","pages":"Article 130389"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetase\",\"authors\":\"Drashti G. Daraji ,&nbsp;Andrew J. Jezewski ,&nbsp;Katy M. Alden ,&nbsp;Jonah P. Propp ,&nbsp;Michael E. Heene ,&nbsp;Calvin A. Soldan ,&nbsp;Lijun Liu ,&nbsp;Kevin P. Battaile ,&nbsp;Scott Lovell ,&nbsp;Bart L. Staker ,&nbsp;Damian J. Krysan ,&nbsp;Timothy J. Hagen\",\"doi\":\"10.1016/j.bmcl.2025.130389\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Acetyl-CoA synthetase (ACS) is a member of the adenylate-forming enzymes superfamily. This enzyme plays a crucial role in cellular metabolism. While ACS enzymes are non-essential in mammals, they are essential in some fungal species and parasites that are pathogenic to humans. Hence, inhibition of the ACS enzyme is an emerging target for the development of novel anti-infectives. Alkyl AMP esters and acyl sulfamoyl adenosine (Acyl-AMS) are potent inhibitors of fungal ACS enzymes by mimicingthe acyl-AMP enzyme intermediate. Molecular docking studies were performed to facilitate the design of analogs and to explore their potential ligand-binding interactions with the ACS enzyme. A series of acyl-AMP isosteres were synthesized and screened for inhibitory activity against fungal ACS enzymes. Notably, Compound <strong>14</strong> was successfully crystallized with the <em>Cryptococcus neoformans</em> ACS1 enzyme, providing valuable structural insight for future inhibitor design.</div></div>\",\"PeriodicalId\":256,\"journal\":{\"name\":\"Bioorganic & Medicinal Chemistry Letters\",\"volume\":\"129 \",\"pages\":\"Article 130389\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic & Medicinal Chemistry Letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0960894X25002987\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960894X25002987","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

乙酰辅酶a合成酶(ACS)是腺苷酸形成酶超家族的成员。这种酶在细胞代谢中起关键作用。虽然ACS酶在哺乳动物中不是必需的,但它们在一些真菌和寄生虫中是必需的,这些真菌和寄生虫对人类具有致病性。因此,抑制ACS酶是开发新型抗感染药物的一个新兴靶点。烷基AMP酯和酰基氨基酰基腺苷(酰基- ams)通过模拟酰基-AMP酶中间体是真菌ACS酶的有效抑制剂。进行分子对接研究以促进类似物的设计,并探索它们与ACS酶的潜在配体结合相互作用。合成了一系列酰基amp同异构体,并对其抑菌活性进行了筛选。值得注意的是,化合物14成功地与新型隐球菌ACS1酶结晶,为未来抑制剂的设计提供了有价值的结构见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Synthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetase

Synthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetase
Acetyl-CoA synthetase (ACS) is a member of the adenylate-forming enzymes superfamily. This enzyme plays a crucial role in cellular metabolism. While ACS enzymes are non-essential in mammals, they are essential in some fungal species and parasites that are pathogenic to humans. Hence, inhibition of the ACS enzyme is an emerging target for the development of novel anti-infectives. Alkyl AMP esters and acyl sulfamoyl adenosine (Acyl-AMS) are potent inhibitors of fungal ACS enzymes by mimicingthe acyl-AMP enzyme intermediate. Molecular docking studies were performed to facilitate the design of analogs and to explore their potential ligand-binding interactions with the ACS enzyme. A series of acyl-AMP isosteres were synthesized and screened for inhibitory activity against fungal ACS enzymes. Notably, Compound 14 was successfully crystallized with the Cryptococcus neoformans ACS1 enzyme, providing valuable structural insight for future inhibitor design.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.70
自引率
3.70%
发文量
463
审稿时长
27 days
期刊介绍: Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信